News – Page 114 – Endpoints News

Novo offers detailed look at semaglutide’s cardiac outcomes in Phase 3 trial as it tees up resubmission

9 months ago

NuCana stops Phase 2 as chemotherapy derivative 'unlikely' to meet primary endpoint

9 months ago

J&J's human resources leader to retire; Amgen becomes the newest pharma with a top AI exec

9 months ago

Updated: Alnylam’s new Phase 3 ATTR data bring uncertainty to standard of care ambitions

9 months ago

FDA’s drug evaluation wing launches new AI oversight panel

9 months ago

Pennsylvania judge sides with drugmakers on first steps for growing GLP-1 lawsuits

9 months ago

FDA hints at what Chevron's elimination means in new SCOTUS filing

9 months ago

Corrected: Afrigen, CEPI to speed up mRNA vaccine manufacturing; Bora Pharma invests in Tanvex

9 months ago

Ahead of acquisition by Novo Holdings, are Catalent’s dark days behind it?

9 months ago

Recursion nears ‘moment of truth’ with first key data, kicking off 18-month flurry of readouts

9 months ago

J&J heads to FDA for Vyvgart competitor; Tokyo conglomerate launches venture fund

9 months ago

Merck ends two Phase 3 studies of Keytruda, including an early-stage non-small cell lung cancer trial

9 months ago

Preclinical team hit hardest in Repare's R&D prioritization, layoffs

9 months ago

BioMarin lays off 225 employees as it cuts spending on gene therapy rollout

9 months ago

How an upstart pharmacy benefit manager has been winning over companies like TikTok and Zoom

9 months ago

UK government partners with pharma on new £400M life science infusion

9 months ago

Delaware high court to review expert testimony in Zantac suits, in win for drugmakers

9 months ago

Regeneron sues Sandoz to halt biosimilar to its blockbuster eye drug

9 months ago

House Oversight chair tells PBM CEOs to correct testimonies from July hearing

9 months ago

Sanofi pauses supply of two flu vaccines in China over ‘unexpected circumstances’

9 months ago

FDA warns EyePoint over eye implant manufacturing woes

9 months ago

SpringWorks gets priority review; Botox competitor data; Hyundai's Covid treatment; Arcus takes a loan

9 months ago

Novartis seeks to expand Leqvio into heart disease prevention

9 months ago

Novartis partners with small North Carolina biotech to make its biologics more 'convenient'

9 months ago

First page Previous page 111 112 113114115 116 117 Next page Last page